SCTX
SCTX
US8110331092
Scribe Therapeutics Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Market & Enterprise Value
Market Cap
400.78M EUR
--
Enterprise Value
484.67M EUR
--
Valuation Multiples
Trailing P/E
--
--
Forward P/E
-5.85x
--
Price to Sales
12.03x
--
Price to Book
--
--
EV/Revenue
14.55x
--
EV/EBITDA
-17.42x
--
Price to FCF (P/FCF)
--
--
EV/FCF
--
--
FCF Yield
--
--
ende